0000950123-23-004668.txt : 20230512
0000950123-23-004668.hdr.sgml : 20230512
20230512130237
ACCESSION NUMBER: 0000950123-23-004668
CONFORMED SUBMISSION TYPE: 13F-HR
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20230331
FILED AS OF DATE: 20230512
DATE AS OF CHANGE: 20230512
EFFECTIVENESS DATE: 20230512
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: BioImpact Capital LLC
CENTRAL INDEX KEY: 0001687078
IRS NUMBER: 364818254
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 13F-HR
SEC ACT: 1934 Act
SEC FILE NUMBER: 028-20107
FILM NUMBER: 23914497
BUSINESS ADDRESS:
STREET 1: 399 BOYLSTON STREET, SUITE 1100
CITY: BOSTON
STATE: MA
ZIP: 02116
BUSINESS PHONE: 6174259200
MAIL ADDRESS:
STREET 1: 399 BOYLSTON STREET, SUITE 1100
CITY: BOSTON
STATE: MA
ZIP: 02116
FORMER COMPANY:
FORMER CONFORMED NAME: MPM Oncology Impact Management LP
DATE OF NAME CHANGE: 20161007
13F-HR
1
primary_doc.xml
X0202
13F-HR
LIVE
0001687078
XXXXXXXX
03-31-2023
03-31-2023
false
BIOIMPACT CAPITAL LLC
399 BOYLSTON STREET, SUITE 1100
BOSTON
MA
02116
13F HOLDINGS REPORT
028-20107
000309865
801-119133
N
Brendan Furey
Chief Compliance Officer
(617) 425-9222
/s/Brendan Furey
Boston
MA
05-12-2023
0
31
384916993
false
INFORMATION TABLE
2
23334.xml
INFORMATION TABLE FOR FORM 13F
Amicus Therapeutics Inc.
Common
03152W109
4306158
388292
SH
SOLE
388292
0
0
Arcutis Biotherapeutics inc
Common
03969K108
2795507
254137
SH
SOLE
254137
0
0
AVROBIO, Inc.
Common
05455M100
647918
647918
SH
SOLE
647918
0
0
Axsome Therapeutics, Inc.
Common
05464T104
4342395
70402
SH
SOLE
70402
0
0
Black Diamond Therapeutics, Inc.
Common
09203E105
273838
144888
SH
SOLE
144888
0
0
Chinook Therapeutics, Inc.
Common
16961L106
4579209
197806
SH
SOLE
197806
0
0
Crinetics Pharmaceuticals Inc.
Common
22663K107
5787896
360392
SH
SOLE
360392
0
0
Cullinan Oncology, Inc.
Common
230031106
78241782
7648268
SH
SOLE
7648268
0
0
Geron Corporation
Common
374163103
18231396
8401565
SH
SOLE
8401565
0
0
Harpoon Therapeutics, Inc.
Common
41358P106
2378350
3196707
SH
SOLE
3196707
0
0
Inhibrx, Inc Com
Common
45720L107
22498342
1192281
SH
SOLE
1192281
0
0
Inozyme Pharma Inc.
Common
45790W108
1339261
233728
SH
SOLE
233728
0
0
Insmed Incorporated
Common
457669307
6806224
399192
SH
SOLE
399192
0
0
Intellia Therapeutics, Inc.
Common
45826J105
21335547
572459
SH
SOLE
572459
0
0
Iovance Biotherapeutics Inc Com
Common
462260100
15977509
2614977
SH
SOLE
2614977
0
0
iTeos Therapeutics, Inc.
Common
46565G104
23762284
1745943
SH
SOLE
1745943
0
0
Iveric Bio Inc
Common
46583P102
25441662
1045691
SH
SOLE
1045691
0
0
Madrigal Pharmaceuticals inc
Common
558868105
8730566
36038
SH
SOLE
36038
0
0
Oncorus, Inc.
Common
68236R103
817699
2377031
SH
SOLE
2377031
0
0
Phathom Pharmaceuticals inc
Common
71722W107
1518071
212615
SH
SOLE
212615
0
0
Provention Bio Inc
Common
74374N102
28288797
1173809
SH
SOLE
1173809
0
0
Reata Pharmaceuticals inc-a
Common
75615P103
16544794
176874
SH
SOLE
176874
0
0
REGENXBIO Inc.
Common
75901B107
11680159
617671
SH
SOLE
617671
0
0
Relay Therapeutics Inc.
Common
75943R102
20186192
1225634
SH
SOLE
1225634
0
0
Repare Therapeutics, Inc.
Common
760273102
16136114
1639849
SH
SOLE
1639849
0
0
Revolution Medicines, Inc.
Common
76155X100
5350497
247022
SH
SOLE
247022
0
0
TCR2 Therapeutics, Inc.
Common
87808K106
5056473
3370982
SH
SOLE
3370982
0
0
Travere Therapeutics Inc.
Common
89422G107
7053809
313642
SH
SOLE
313642
0
0
Uniqure N.V.
Common
N90064101
7013231
348224
SH
SOLE
348224
0
0
Verve Therapeutics, Inc
Common
92539P101
11586484
803501
SH
SOLE
803501
0
0
Werewolf Therapeutics, Inc.
Common
95075A107
6208829
2388011
SH
SOLE
2388011
0
0